A warning on foetal monitoring with cardiotocographs first made in 2002 has been repeated by the Medicines and Healthcare products Regulatory Agency.
Adverse outcomes are still being reported in the presence of CTG traces that appear normal. For example, the display of double maternal heart rate (MHR x 2) can be falsely reassuring, the MHRA warned.
It said cardiotocograph should not be relied upon in isolation to monitor the condition of the foetus and the presence of a foetal heartbeat should also be checked by independent means such as a Pinard stethoscope or hand-held Doppler.
Introducing Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started: